User contributions for Marie Simonyan
A user with 4 edits. Account created on 15 January 2023.
16 January 2023
- 12:3612:36, 16 January 2023 diff hist 0 Abemaciclib Undid revision 1133972009 by Marie Simonyan (talk) Tag: Undo
- 11:0811:08, 16 January 2023 diff hist 0 Abemaciclib No edit summary Tags: Reverted Visual edit: Switched
15 January 2023
- 18:5418:54, 15 January 2023 diff hist −22 User:Marie Simonyan/sandbox No edit summary current
- 18:5318:53, 15 January 2023 diff hist +9,883 N User:Marie Simonyan/sandbox ←Created page with '{{User sandbox}} <!-- EDIT BELOW THIS LINE --> '''Abemaciclib''', sold under the brand name '''Verzenio''' among others, is a medication for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6.[2] Abemaciclib, վաճառվում է բրենդային Verzenio անվան տակ, ի թիվս այլոց, դեղամիջոց է կրծքագեղձի առաջավոր կա...'
